Approval · Notice of Compliance 26835 · 2021
OPSYNVI: Notice of Compliance 26835
Issued October 14, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26835
- Date
- October 14, 2021
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OPSYNVI | 02521083 | Marketed |
Medicinal ingredients
- TADALAFIL 40 MG per TAB
- MACITENTAN 10 MG per TAB